Colonic PolypsNCT04749277
Artificial Intelligence in the Characterization of Colorectal Polyps
An observational study of Colonic Polyps, run by Unidade Local de Saúde de Coimbra, EPE at 1 site in Portugal.
Trial summary
Current guidelines recommend resection and histopathological analyses of all colorectal polyps. Real-time optical diagnosis can obviate non-neoplastic polyp resection ("diagnose-and-leave-behind") and histopathological analyses of diminutive polyps ("predict-resect-and-discard") reducing healthcare and cost burden. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colonic Polyps
- What is being tested?
- CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)
- How many people
- 197 participants
- Where
- 1 sitePortugal
- Study dates
- 1 Jan 2021to 30 Apr 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.
Who may be able to join
- Age ≥18 years;
- The presence of at least one polyp in an elective colonoscopy.
Who cannot join
- Poor bowel preparation (Boston Bowel Preparation Score <6 at the total score or <2 at one of colorectal segment);
- No recovery of excised polyps for histopathological analysis;
- The presence of polyps not amenable to endoscopic excision or with contraindication for their excision at the time of colonoscopy;
- The absence of explicit indication for colonoscopy.
Trial locations and contacts
1 site in 1 country.
Portugal1 site
Centro Hospitalar e Universitário de Coimbra
Coimbra, 3000-075
About this study
Official title: Artificial Intelligence in the Characterization of Small and Diminutive Colorectal Polyps: A Prospective Study in a Clinical Setting Using CAD EYE®
Current guidelines recommend resection and histopathological analyses of all colorectal polyps. Real-time optical diagnosis can obviate non-neoplastic polyp resection ("diagnose-and-leave-behind") and histopathological analyses of diminutive polyps ("predict-resect-and-discard") reducing healthcare and cost burden. The investigators aimed to evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® (Fujifilm,Germany) in real-time optical characterization of colorectal polyps compared to endoscopic diagnosis with histopathology as the gold-standard. For this purpose, a single-centre prospective study of diminutive/small colorectal polyps is ongoing.
Read the detailed description
Introduction Worldwide, colorectal cancer (CRC) is the 4th most frequent cancer and the 3rd cause of cancer-related death. In Portugal, CRC is the 3rd most common cause and the 2nd leading cause of cancer-related mortality. In colorectal carcinogenesis, colorectal polyps (adenomatous or serrated polyps) are considered premalignant lesions. The detection of colorectal polyps and subsequent resection is effective in reducing CRC incidence and mortality and the risk of interval CRC, and is the crucial aspect of CRC prevention. Considering the detection of colorectal polyps, there is a wide variation among endoscopists in terms of skills for the detection of adenomas, the major premalignant lesions of CRC, translated into the detection rate of adenomas (ADR). ADR is considered a marker of careful inspection of colorectal mucosa, translating quality in colonoscopy, which is inversely associated with the risk of interval CRC or cancer-related death. In the context of screening colonoscopy, the minimum ADR is 25% to reduce the risk of interval CRC and death, being predictably higher if a positive fecal occult blood test is found, although the exact value still remains to be elucidated. The detection rate of serrated polyps has been strongly correlated with ADR.
About 50% of small polyps are non-adenomatous and these polyps have no malignancy potential, especially for small polyps, whose cancer risk is extremely low (0-0.6%). The resection of these non-adenomatous polyps may increase medical costs and risks related to post-polypectomy complications (bleeding, perforation).
Real time optical diagnosis by artificial intelligence can improve the cost-benefit and efficiency of colonoscopy as an auxiliary tool in the decision making of which polyps should be resected and which polyps should be recovered for histological characterization. However, its practical application implies a negative predictive value ≥ 90% in optical diagnosis in order to don´t have implications in terms of interval CRC and medico-legal issues.
CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany) is a fully-automated computer program, which allows the detection of colorectal polyps as well as their histological classification using the artificial intelligence technology using deep learning, so-called REilI. When applied in a high-quality colonoscopy, it seems to improve the detection rate of polyps and the ADR in real time, during colonoscopy course. In fact, the detection of difficult lesions remains one of the major challenges in the endoscopy field in last years, particularly for flat lesions, multiple polyps and polyps located at the image periphery. The detection of colorectal polyps is shown by 3 simultaneous identifiers, 2 visual and 1 auditory. The visual identifiers correspond to a detection box in the area of suspected polyps and a semicircle at the periphery of the image, corresponding to the quadrant where the suspect polyps are located. The auditory stimulus corresponds to a volume adjustable sound signal emitted when a suspect polyps is detected. Regarding the optical characterization of histopathology, colo-rectal polyps are classified into 2 types, hyperplastic (green colour), which include hyperplastic and serrated polyps, and neoplastic (yellow colour), for adenomas and adenocarcinomas. In addition, it allows to perform this characterization in 3 confidence levels and the mapping of the position of the suspected area.
This system allows the storage of videos related to both detection and characterization of colorectal polyps, one of the recognized quality tools in colonoscopy.
The detection mode of colorectal polyps is performed in white light imaging (WLI) or Linked Colour Imaging (LCI), while the optical characterization is performed in Blue Light Imaging (BLI) mode, without the need to fix or zoom the image. This tool is user-friendly, simple, intuitive and does not interfere with colonoscopy images.
Objectives
Primary objectives
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy;
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis.
Secondary objectives
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of dimension (≤5, 6-9mm and ≥10mm), location and histological type (hyperplastic, serrated sessile lesion, adenoma, adenocarcinoma);
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps according to the experience of the endoscopist.
Population and methodology
Type of study Prospective observational cohort study
Type of sample The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.
Study design All colonoscopies will be performed by the endoscopist (trainee and experienced endoscopist) using CAD EYE® in detection mode (WLI or LCI), during colonoscopy retrieval. When a suspected polyp is identified by the endoscopist, optical characterization is performed by the endoscopist in WLI and BLI modes, in a first phase and by the CAD EYE® with BLI, in a second phase.
Methods plan Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)
Phase 2. CAD EYE® system applied during colonoscopy retrieval:
2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization
Detailed explanation of Methods phases Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI) Virtual chromoendoscopy training should be performed online through the BASIC e-learning platform (bli.eu/category/e-learning/). This training should be carried out by all participants enrolled in the project (trainees and experienced endoscopists) before its practical application, which will allow skills acquisition on the characterization of virtual chromoendoscopy of colorectal polyps using BLI. Additionally, a brief review of the Kudo classification of pit pattern of colorectal polyps should be carried out.
Phase 2. Evaluation of colorectal polyps in real-time - Optical characterization of colorectal polyps The first approach on optical characterization of an identified polyp consists in the evaluation of the polyp, first in WLI mode and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, and the evaluation of both should be recorded on a separate record sheet by the endoscopist who is not performing the examination. The two endoscopists should preferably (but not necessarily) be an experienced endoscopist and a trainee from the last few years, and the presence of at least one experienced endoscopist is mandatory. The independent evaluation is guaranteed by a phased and recorded approach: 1st step - The 1st endoscopist (endoscopist performing colonoscopy) request the polyp evaluation and written record by the 2nd endoscopist (the one who is not performing the colonoscopy) - blinded evaluation because the 1st endoscopist doesn't verbalize his evaluation); 2nd moment - when the 2nd endoscopist signals that he has completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include the histopathological type of polyp (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low). Kudo classification of pit pattern can also be recorded (optional).
Afterwards, optical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet.
The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done.
Phase 3. Histopathological evaluation (by pathologist with gastrointestinal expertise) After detection and optical characterization of identified colorectal polyps, their resection should be performed by the most appropriate technique according to the size and type of polyp (cold forceps polypectomy if dimensions <3mm), cold snare polypectomy if dimension between 3-10mm and diathermic snare polypectomy/endoscopic mucosal resection if lesions >10mm) and recovery of colorectal polyp for anatomopathological characterization. Each colorectal polyp should be recovered to a separate vial. Unrecovered polyps will not be counted for comparative evaluation of optical characterization.
Statistical analysis The diagnostic performance of CAD EYE® will be evaluated by comparison with the gold standard (histological characterization in the optical characterization phase), in terms of diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive value. Sub-analysis can be performed regarding the size, location and histological type of polyp, as well as the expertise of the endoscopist.
Sample size calculation For an alpha risk of 0.05 and beta risk of 0.2 for a bilateral test, it will be necessary to include 197 colorectal polyps assuming the initial pre-intervention diagnostic ratio is 0.7 and the final after-intervention ratio is 0.82.
Expected Results It is expected that the new CAD EYE® system will have a diagnostic accuracy in the optical characterization of colorectal polyps around 78.4%, comparable to experienced endoscopists (78.4% vs 79.6%) and superior to less experienced endoscopists (70.7% vs 79.6%).(14) Thus, the new CAD EYE® system will allow optical characterization with high accuracy impacting as a decision making tool for the endoscopist in strategies based on optical diagnosis such as "diagnosis and leave behind" for diminutive polyps from sigmoid colon and rectum with high degree of confidence in hyperplastic histology and "predict, resect and discard" for diminutive polyps.
- Conditions
- Colonic Polyps
- Being tested
- CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)
- Keywords
- Artificial Intelligence, Colonoscopy, Colonic Polyps
- Medical subject headings
- Colonic Polyps
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)Other
Methods plan
Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)
Phase 2. CAD EYE® system applied during colonoscopy retrieval:
2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization
| Study group | Role | What they receive |
|---|---|---|
| Endoscopist characterization on WLI and BLI modes | Optical characterization of an identified polyp, first in WLI and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, preferably (but not necessarily) an experienced endoscopist and a trainee. The presence of at least one experienced endoscopist is mandatory. An independent evaluation is guaranteed. First step - The 1st endoscopist (who performing colonoscopy) request the polyp evaluation and record written by the 2nd endoscopist (who not performing the colonoscopy) - blinded evaluation since 1st endoscopist doesn't verbalize his evaluation); 2nd step - when the 2nd endoscopist signals that he completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include polyp histological type (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low). | |
| CAD EYE® characterization on BLI mode | Optical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet. The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done. Receives: Other: CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Real-time optical characterization of colorectal polyps (CAD EYE® versus Histopathology)
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis
Measured: 2 months
Real-time optical characterization of colorectal polyps (Endoscopist versus Histopathology)
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy by endoscopists
Measured: 2 months
Secondary outcomes (4)
Real-time optical characterization of colorectal polyps according to polyps size
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of dimension (≤5, 6-9mm and ≥10mm)
Measured: 2 months
Real-time optical characterization of colorectal polyps according to polyps location
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of location (right and left colon)
Measured: 2 months
Real-time optical characterization of colorectal polyps according to polyps histological type
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of histological type (hyperplastic, serrated sessile lesion, adenoma, adenocarcinoma)
Measured: 2 months
Real-time optical characterization of colorectal polyps according to endoscopist experience
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps according to the experience of the endoscopist (trainee and experienced endoscopists)
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Feb 2021
- Study start1 Jan 2021
- Primary completion28 Feb 2021
- Study completion30 Apr 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (19)Papers the sponsor has linked to this study.
- Other trials for Colonic PolypsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 197 participants (actual)
Sponsor and investigators
- Lead sponsor
- Unidade Local de Saúde de Coimbra, EPE
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elisa Gravito-Soares, Unidade Local de Saúde de Coimbra, EPE
- Investigators
- Elisa Gravito-Soares, MD, Principal investigator, Unidade Local de Saúde de Coimbra, EPE
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04749277
- Sponsor's protocol ID
- CHUCoimbra
- Status last verified
- Jul 2021
- First submitted
- 31 Jan 2021
- Last updated
- 28 Jul 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol. 2016 Mar;111(3):355-65. doi: 10.1038/ajg.2015.418. Epub 2016 Jan 12.
PubMed 26753884Bretthauer M, Kaminski MF, Loberg M, Zauber AG, Regula J, Kuipers EJ, Hernan MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp-Vogelaar I, Garborg K, Rupinski M, Spaander MC, Bugajski M, Hoie O, Stefansson T, Hoff G, Adami HO; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group. Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 1;176(7):894-902. doi: 10.1001/jamainternmed.2016.0960.
PubMed 27214731Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19.
PubMed 26896459Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667.
PubMed 20463339Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086.
PubMed 24693890van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. doi: 10.1111/j.1572-0241.2006.00390.x.
PubMed 16454841Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2017 Apr;5(3):309-334. doi: 10.1177/2050640617700014. Epub 2017 Mar 16.
PubMed 28507745Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, Jover R, Langner C, Bronzwaer M, Nalankilli K, Fockens P, Hazzan R, Gralnek IM, Gschwantler M, Waldmann E, Jeschek P, Penz D, Heresbach D, Moons L, Lemmers A, Paraskeva K, Pohl J, Ponchon T, Regula J, Repici A, Rutter MD, Burgess NG, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017 Mar;49(3):270-297. doi: 10.1055/s-0043-102569. Epub 2017 Feb 17.
PubMed 28212588Min M, Su S, He W, Bi Y, Ma Z, Liu Y. Computer-aided diagnosis of colorectal polyps using linked color imaging colonoscopy to predict histology. Sci Rep. 2019 Feb 27;9(1):2881. doi: 10.1038/s41598-019-39416-7.
PubMed 30814661Brenner H, Altenhofen L, Kretschmann J, Rosch T, Pox C, Stock C, Hoffmeister M. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. Gastroenterology. 2015 Aug;149(2):356-66.e1. doi: 10.1053/j.gastro.2015.04.012. Epub 2015 Apr 22.
PubMed 25911510van der Zander QEW, Schreuder RM, Fonolla R, Scheeve T, van der Sommen F, Winkens B, Aepli P, Hayee B, Pischel AB, Stefanovic M, Subramaniam S, Bhandari P, de With PHN, Masclee AAM, Schoon EJ. Optical diagnosis of colorectal polyp images using a newly developed computer-aided diagnosis system (CADx) compared with intuitive optical diagnosis. Endoscopy. 2021 Dec;53(12):1219-1226. doi: 10.1055/a-1343-1597. Epub 2021 Mar 10.
PubMed 33368056Weigt J, Repici A, Antonelli G, Afifi A, Kliegis L, Correale L, Hassan C, Neumann H. Performance of a new integrated computer-assisted system (CADe/CADx) for detection and characterization of colorectal neoplasia. Endoscopy. 2022 Feb;54(2):180-184. doi: 10.1055/a-1372-0419. Epub 2021 Apr 20.
PubMed 33494106Lui TKL, Guo CG, Leung WK. Accuracy of artificial intelligence on histology prediction and detection of colorectal polyps: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Jul;92(1):11-22.e6. doi: 10.1016/j.gie.2020.02.033. Epub 2020 Feb 29.
PubMed 32119938van de Wetering AJP, Meulen LWT, Bogie RMM, van der Zander QEW, Reumkens A, Winkens B, Cheng HR, Straathof JA, Dekker E, Keulen E, Bakker CM, Hoge C, de Ridder R, Masclee AAM, Sanduleanu-Dascalescu S. Optical diagnosis of diminutive polyps in the Dutch Bowel Cancer Screening Program: Are we ready to start? Endosc Int Open. 2020 Mar;8(3):E257-E265. doi: 10.1055/a-1072-4853. Epub 2020 Feb 21.
PubMed 32118099Song EM, Park B, Ha CA, Hwang SW, Park SH, Yang DH, Ye BD, Myung SJ, Yang SK, Kim N, Byeon JS. Endoscopic diagnosis and treatment planning for colorectal polyps using a deep-learning model. Sci Rep. 2020 Jan 8;10(1):30. doi: 10.1038/s41598-019-56697-0.
PubMed 31913337
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Artificial Intelligence in the Characterization of Small and Diminutive Colorectal Polyps: A Prospective Study in a Clinical Setting Using CAD EYE®
- ClinicalTrials.gov ID
- NCT04749277
- Acronym / sponsor ID
- CHUCoimbra
- Conditions
- Colonic Polyps
- Keywords
- Artificial Intelligence, Colonoscopy, Colonic Polyps
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 197 participants (actual)
- Lead sponsor
- Unidade Local de Saúde de Coimbra, EPEUniversity, hospital or other
- Study start
- 1 Jan 2021 (actual)
- Primary completion
- 28 Feb 2021 (actual)
- Study completion
- 30 Apr 2021 (actual)
- First posted
- 11 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Current guidelines recommend resection and histopathological analyses of all colorectal polyps. Real-time optical diagnosis can obviate non-neoplastic polyp resection ("diagnose-and-leave-behind") and histopathological analyses of diminutive polyps ("predict-resect-and-discard") reducing healthcare and cost burden. The investigators aimed to evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® (Fujifilm,Germany) in real-time optical characterization of colorectal polyps compared to endoscopic diagnosis with histopathology as the gold-standard. For this purpose, a single-centre prospective study of diminutive/small colorectal polyps is ongoing.
Detailed description
Introduction Worldwide, colorectal cancer (CRC) is the 4th most frequent cancer and the 3rd cause of cancer-related death. In Portugal, CRC is the 3rd most common cause and the 2nd leading cause of cancer-related mortality. In colorectal carcinogenesis, colorectal polyps (adenomatous or serrated polyps) are considered premalignant lesions. The detection of colorectal polyps and subsequent resection is effective in reducing CRC incidence and mortality and the risk of interval CRC, and is the crucial aspect of CRC prevention. Considering the detection of colorectal polyps, there is a wide variation among endoscopists in terms of skills for the detection of adenomas, the major premalignant lesions of CRC, translated into the detection rate of adenomas (ADR). ADR is considered a marker of careful inspection of colorectal mucosa, translating quality in colonoscopy, which is inversely associated with the risk of interval CRC or cancer-related death. In the context of screening colonoscopy, the minimum ADR is 25% to reduce the risk of interval CRC and death, being predictably higher if a positive fecal occult blood test is found, although the exact value still remains to be elucidated. The detection rate of serrated polyps has been strongly correlated with ADR.
About 50% of small polyps are non-adenomatous and these polyps have no malignancy potential, especially for small polyps, whose cancer risk is extremely low (0-0.6%). The resection of these non-adenomatous polyps may increase medical costs and risks related to post-polypectomy complications (bleeding, perforation).
Real time optical diagnosis by artificial intelligence can improve the cost-benefit and efficiency of colonoscopy as an auxiliary tool in the decision making of which polyps should be resected and which polyps should be recovered for histological characterization. However, its practical application implies a negative predictive value ≥ 90% in optical diagnosis in order to don´t have implications in terms of interval CRC and medico-legal issues.
CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany) is a fully-automated computer program, which allows the detection of colorectal polyps as well as their histological classification using the artificial intelligence technology using deep learning, so-called REilI. When applied in a high-quality colonoscopy, it seems to improve the detection rate of polyps and the ADR in real time, during colonoscopy course. In fact, the detection of difficult lesions remains one of the major challenges in the endoscopy field in last years, particularly for flat lesions, multiple polyps and polyps located at the image periphery. The detection of colorectal polyps is shown by 3 simultaneous identifiers, 2 visual and 1 auditory. The visual identifiers correspond to a detection box in the area of suspected polyps and a semicircle at the periphery of the image, corresponding to the quadrant where the suspect polyps are located. The auditory stimulus corresponds to a volume adjustable sound signal emitted when a suspect polyps is detected. Regarding the optical characterization of histopathology, colo-rectal polyps are classified into 2 types, hyperplastic (green colour), which include hyperplastic and serrated polyps, and neoplastic (yellow colour), for adenomas and adenocarcinomas. In addition, it allows to perform this characterization in 3 confidence levels and the mapping of the position of the suspected area.
This system allows the storage of videos related to both detection and characterization of colorectal polyps, one of the recognized quality tools in colonoscopy.
The detection mode of colorectal polyps is performed in white light imaging (WLI) or Linked Colour Imaging (LCI), while the optical characterization is performed in Blue Light Imaging (BLI) mode, without the need to fix or zoom the image. This tool is user-friendly, simple, intuitive and does not interfere with colonoscopy images.
Objectives
Primary objectives
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy;
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis.
Secondary objectives
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of dimension (≤5, 6-9mm and ≥10mm), location and histological type (hyperplastic, serrated sessile lesion, adenoma, adenocarcinoma);
- To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps according to the experience of the endoscopist.
Population and methodology
Type of study Prospective observational cohort study
Type of sample The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.
Study design All colonoscopies will be performed by the endoscopist (trainee and experienced endoscopist) using CAD EYE® in detection mode (WLI or LCI), during colonoscopy retrieval. When a suspected polyp is identified by the endoscopist, optical characterization is performed by the endoscopist in WLI and BLI modes, in a first phase and by the CAD EYE® with BLI, in a second phase.
Methods plan Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)
Phase 2. CAD EYE® system applied during colonoscopy retrieval:
2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization
Detailed explanation of Methods phases Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI) Virtual chromoendoscopy training should be performed online through the BASIC e-learning platform (bli.eu/category/e-learning/). This training should be carried out by all participants enrolled in the project (trainees and experienced endoscopists) before its practical application, which will allow skills acquisition on the characterization of virtual chromoendoscopy of colorectal polyps using BLI. Additionally, a brief review of the Kudo classification of pit pattern of colorectal polyps should be carried out.
Phase 2. Evaluation of colorectal polyps in real-time - Optical characterization of colorectal polyps The first approach on optical characterization of an identified polyp consists in the evaluation of the polyp, first in WLI mode and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, and the evaluation of both should be recorded on a separate record sheet by the endoscopist who is not performing the examination. The two endoscopists should preferably (but not necessarily) be an experienced endoscopist and a trainee from the last few years, and the presence of at least one experienced endoscopist is mandatory. The independent evaluation is guaranteed by a phased and recorded approach: 1st step - The 1st endoscopist (endoscopist performing colonoscopy) request the polyp evaluation and written record by the 2nd endoscopist (the one who is not performing the colonoscopy) - blinded evaluation because the 1st endoscopist doesn't verbalize his evaluation); 2nd moment - when the 2nd endoscopist signals that he has completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include the histopathological type of polyp (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low). Kudo classification of pit pattern can also be recorded (optional).
Afterwards, optical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet.
The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done.
Phase 3. Histopathological evaluation (by pathologist with gastrointestinal expertise) After detection and optical characterization of identified colorectal polyps, their resection should be performed by the most appropriate technique according to the size and type of polyp (cold forceps polypectomy if dimensions <3mm), cold snare polypectomy if dimension between 3-10mm and diathermic snare polypectomy/endoscopic mucosal resection if lesions >10mm) and recovery of colorectal polyp for anatomopathological characterization. Each colorectal polyp should be recovered to a separate vial. Unrecovered polyps will not be counted for comparative evaluation of optical characterization.
Statistical analysis The diagnostic performance of CAD EYE® will be evaluated by comparison with the gold standard (histological characterization in the optical characterization phase), in terms of diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive value. Sub-analysis can be performed regarding the size, location and histological type of polyp, as well as the expertise of the endoscopist.
Sample size calculation For an alpha risk of 0.05 and beta risk of 0.2 for a bilateral test, it will be necessary to include 197 colorectal polyps assuming the initial pre-intervention diagnostic ratio is 0.7 and the final after-intervention ratio is 0.82.
Expected Results It is expected that the new CAD EYE® system will have a diagnostic accuracy in the optical characterization of colorectal polyps around 78.4%, comparable to experienced endoscopists (78.4% vs 79.6%) and superior to less experienced endoscopists (70.7% vs 79.6%).(14) Thus, the new CAD EYE® system will allow optical characterization with high accuracy impacting as a decision making tool for the endoscopist in strategies based on optical diagnosis such as "diagnosis and leave behind" for diminutive polyps from sigmoid colon and rectum with high degree of confidence in hyperplastic histology and "predict, resect and discard" for diminutive polyps.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Endoscopist characterization on WLI and BLI modes | – | –Optical characterization of an identified polyp, first in WLI and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, preferably (but not necessarily) an experienced endoscopist and a trainee. The presence of at least one experienced endoscopist is mandatory. An independent evaluation is guaranteed. First step - The 1st endoscopist (who performing colonoscopy) request the polyp evaluation and record written by the 2nd endoscopist (who not performing the colonoscopy) - blinded evaluation since 1st endoscopist doesn't verbalize his evaluation); 2nd step - when the 2nd endoscopist signals that he completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include polyp histological type (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low). |
| CAD EYE® characterization on BLI mode | – | Other: CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)Optical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet. The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.
Key inclusion criteria (2 listed)
- Age ≥18 years;
- The presence of at least one polyp in an elective colonoscopy.
Key exclusion criteria (4 listed)
- Poor bowel preparation (Boston Bowel Preparation Score <6 at the total score or <2 at one of colorectal segment);
- No recovery of excised polyps for histopathological analysis;
- The presence of polyps not amenable to endoscopic excision or with contraindication for their excision at the time of colonoscopy;
- The absence of explicit indication for colonoscopy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)Methods plan Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI) Phase 2. CAD EYE® system applied during colonoscopy retrieval: 2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization | Other | CAD EYE® characterization on BLI mode |
Primary outcome
Real-time optical characterization of colorectal polyps (CAD EYE® versus Histopathology)
Time frame: 2 months
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis
Real-time optical characterization of colorectal polyps (Endoscopist versus Histopathology)
Time frame: 2 months
To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy by endoscopists
4 secondary outcomes
Real-time optical characterization of colorectal polyps according to polyps size
Time frame: 2 months
Real-time optical characterization of colorectal polyps according to polyps location
Time frame: 2 months
Real-time optical characterization of colorectal polyps according to polyps histological type
Time frame: 2 months
Real-time optical characterization of colorectal polyps according to endoscopist experience
Time frame: 2 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2021.
- Background: PubMed 26753884Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol. 2016 Mar;111(3):355-65. doi: 10.1038/ajg.2015.418. Epub 2016 Jan 12.
- Background: PubMed 27214731Bretthauer M, Kaminski MF, Loberg M, Zauber AG, Regula J, Kuipers EJ, Hernan MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp-Vogelaar I, Garborg K, Rupinski M, Spaander MC, Bugajski M, Hoie O, Stefansson T, Hoff G, Adami HO; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group. Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 1;176(7):894-902. doi: 10.1001/jamainternmed.2016.0960.
- Background: PubMed 26896459Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19.
- Background: PubMed 20463339Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667.
- Background: PubMed 24693890Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086.
- Background: PubMed 16454841van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. doi: 10.1111/j.1572-0241.2006.00390.x.
- Background: PubMed 28507745Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2017 Apr;5(3):309-334. doi: 10.1177/2050640617700014. Epub 2017 Mar 16.
- Background: PubMed 28212588Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, Jover R, Langner C, Bronzwaer M, Nalankilli K, Fockens P, Hazzan R, Gralnek IM, Gschwantler M, Waldmann E, Jeschek P, Penz D, Heresbach D, Moons L, Lemmers A, Paraskeva K, Pohl J, Ponchon T, Regula J, Repici A, Rutter MD, Burgess NG, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017 Mar;49(3):270-297. doi: 10.1055/s-0043-102569. Epub 2017 Feb 17.
- Background: PubMed 30814661Min M, Su S, He W, Bi Y, Ma Z, Liu Y. Computer-aided diagnosis of colorectal polyps using linked color imaging colonoscopy to predict histology. Sci Rep. 2019 Feb 27;9(1):2881. doi: 10.1038/s41598-019-39416-7.
- Background: PubMed 25911510Brenner H, Altenhofen L, Kretschmann J, Rosch T, Pox C, Stock C, Hoffmeister M. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. Gastroenterology. 2015 Aug;149(2):356-66.e1. doi: 10.1053/j.gastro.2015.04.012. Epub 2015 Apr 22.
- Background: PubMed 33368056van der Zander QEW, Schreuder RM, Fonolla R, Scheeve T, van der Sommen F, Winkens B, Aepli P, Hayee B, Pischel AB, Stefanovic M, Subramaniam S, Bhandari P, de With PHN, Masclee AAM, Schoon EJ. Optical diagnosis of colorectal polyp images using a newly developed computer-aided diagnosis system (CADx) compared with intuitive optical diagnosis. Endoscopy. 2021 Dec;53(12):1219-1226. doi: 10.1055/a-1343-1597. Epub 2021 Mar 10.
- Background: PubMed 33494106Weigt J, Repici A, Antonelli G, Afifi A, Kliegis L, Correale L, Hassan C, Neumann H. Performance of a new integrated computer-assisted system (CADe/CADx) for detection and characterization of colorectal neoplasia. Endoscopy. 2022 Feb;54(2):180-184. doi: 10.1055/a-1372-0419. Epub 2021 Apr 20.
- World Health Organization International Agency for Research on Cancer (IARC). Global Cancer Observatory 2018: estimated cancer incidence and mortality worldwide in 2018. \[homepage on the internet\]. Available from: https://gco.iarc.frLink provided by the sponsor.
- CAD EYE® (Fujifilm,Germany)Link provided by the sponsor.
- CAD EYE® (Fujifilm,Germany)Link provided by the sponsor.
- CAD EYE® (Fujifilm,Germany)Link provided by the sponsor.
- CAD EYE® (Fujifilm,Germany)Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Colonic Polyps
Recruiting
Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
Colonic Neoplasms
RecruitingObservational study
KLF4 Epigenetic Modulation
KLF4 Methylation, Epigenetic
RecruitingObservational study
Malignant Polyp Registry
Malignant Colorectal Polyp, Colorectal Cancer
Active, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
Colon Cancer, Colon Polyp
Enrolling by invitation
Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection
Colon Polyp, Colon Adenoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Elisa Gravito-Soares, MD principal investigator
Unidade Local de Saúde de Coimbra, EPE
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colonic Polyps, run by Unidade Local de Saúde de Coimbra, EPE at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Real-time optical characterization of colorectal polyps (CAD EYE® versus Histopathology) (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04749277, which also lists 19 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.